Advanced search
Publication Cover
Current Medical Research and Opinion Volume 39, 2023 - Issue 8
Submit an article Journal homepage
164
Views
0
CrossRef citations to date
0
Altmetric
Pain Medicine

Prescription opioid utilization patterns, and associated outcomes, among privately insured patients prescribed opioids to manage pain associated with osteoarthritis

Patricia Schepmana Pfizer Inc, New York City, NY, USA
,
J. Bradford Riceb Analysis Group Inc, Boston, MA, USACorrespondence[email protected]
,
Craig G. Becka Pfizer Inc, New York City, NY, USA
,
Alan Whiteb Analysis Group Inc, Boston, MA, USA
,
Rebecca L. Robinsonc Eli Lilly Inc, Indianapolis, IN, USA
,
Sheena Thakkara Pfizer Inc, New York City, NY, USA
,
Catherine Fernanb Analysis Group Inc, Boston, MA, USA
,
Birol Emira Pfizer Inc, New York City, NY, USA
&
Stuart Silvermand David Geffen School of Medicine of University of California, Los Angeles, CA, USA;e Cedars-Sinai Medical Center, Los Angeles, CA, USA
 show all
Pages 1147-1156 | Received 23 Dec 2021, Accepted 06 Jul 2023, Published online: 20 Jul 2023

References

  • Centers for Disease Control. Disability and health related conditions. 2021. https://www.cdc.gov/ncbddd/disabilityandhealth/relatedconditions.html. Accessed June 14, 2021.
  • Centers for Disease Control. Osteoarthritis (OA). 2021. https://www.cdc.gov/arthritis/basics/osteoarthritis.htm. Accessed June 14, 2021.
  • Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020;72(2):220–233. doi: 10.1002/art.41142.
  • Bannuru RR, Osani M, Vaysbrot E, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578–1589. doi: 10.1016/j.joca.2019.06.011.
  • Preston KL, Jasinski DR, Testa M. Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alcohol Depend. 1991;27(1):7–17. doi: 10.1016/0376-8716(91)90081-9.
  • Makunts T, U A, Atayee RS, et al. Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids. Sci Rep. 2019;9(1):12490. doi: 10.1038/s41598-019-48955-y.
  • Rice JB, Kirson NY, Shei A, et al. Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims data. Appl Health Econ Health Policy. 2014;12(4):435–446. doi: 10.1007/s40258-014-0102-0.
  • Dunn KE, Bergeria CL, Huhn AS, et al. A systematic review of laboratory evidence for the abuse potential of tramadol in humans. Front Psychiatry. 2019;10:704. doi: 10.3389/fpsyt.2019.00704.
  • Silverman S, Rice JB, White AG, et al. Clinical and economic burden of prescribing tramadol and other opioids for patients with osteoarthritis in a Commercially-Insured population in the United States. Pain. 2022;163(1):75–82. (under review). doi: 10.1097/j.pain.0000000000002300.
  • Nalamachu S, Robinson RL, Viktrup L, et al. Pain severity and healthcare resource utilization in patients with osteoarthritis in the United States. Postgrad Med. 2021;133(1):10–19. doi: 10.1080/00325481.2020.1841988.
  • Graham J, Novosat T, Sun H, et al. POS1089 association between pain severity and healthcare utilization in an osteoarthritis population: an 18-year retrospective cohort study. Ann Rheum Dis. 2021;80(Suppl 1):824.1–824. doi: 10.1136/annrheumdis-2021-eular.523.
  • Dysart S, Utkina K, Stong L, et al. Insights from real-world analysis of treatment patterns in patients with newly diagnosed knee osteoarthritis. Am Health Drug Benefits. 2021;14(2):56–62.
  • Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682. doi: 10.1093/aje/kwq433.
  • Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424. doi: 10.1080/00273171.2011.568786.
  • Silverman S, Rice JB, White AG, et al. Clinical and economic burden of prescribing tramadol and other opioids for patients with osteoarthritis in a commercially insured population in the United States. Pain. 2022;163(1):75–82. doi: 10.1097/j.pain.0000000000002300.
  • Lee YC, Lu B, Guan H, et al. Physician prescribing patterns and risk of future long-term opioid use among patients with rheumatoid arthritis: a prospective observational cohort study. Arthritis Rheumatol. 2020;72(7):1082–1090. doi: 10.1002/art.41240.
  • Silverman S, Schepman P, Rice JB, et al. A harm reduction model to assess the impact of new treatments for pain over standard of care among patients with osteoarthritis. JMCP. 2021;27(12):1652–1660. doi: 10.18553/jmcp.2021.27.12.1652.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.